Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2022 | Story Anthony Mthembu

According to the Gender Equality and Anti-Discrimination Office (GEADO) at the University of the Free State (UFS), an alarming number of transgender and gender-diverse persons at South African institutions of higher learning are consistently met with a great deal of neglect and exclusion. Therefore, it is imperative to constantly shine light on the injustice and violation of their human rights in order to enable spaces that acknowledge their lived realities and uphold their human dignity. 

The importance of the march

As such, the Gender Equality and Anti-Discrimination Office will be hosting a transgender march on the Bloemfontein Campus on 17  May 2022. 

“The aim of this march is to raise awareness about issues of transsexuality and gender-diverse individuals. We hope to accentuate the voices of transgender individuals and gender-diverse persons on our campuses,” expressed Delisile Mngadi, Assistant Officer in the Gender Equality and Anti-Discrimination Office. The march will commence at 09:30 from the Main Gate and will end at the Centenary Complex. In addition, members of the Gender Equality and Anti-Discrimination Office argue that the purpose of the march is to remind members of the UFS community and the society at large that the stories, the voices, and experiences of transgender and gender-diverse individuals do matter.

An invitation to staff and students 

Members of the UFS community, regardless of how they identify, are invited to take part in the march. “It is also important that cishetero persons attend the march; this shows that they stand in support of all gender-diverse persons, and it is also a great opportunity to learn.  Another reason why it is important for cisgender persons to attend the march is because violence and discrimination targeted at transgender persons remain a daily reality on our campuses, which inadvertently maintains heteronormative notions and patriarchal power that validates transphobia and homophobia,” Mngadi indicated. 

UFS staff and students who will be in attendance can expect to hear speeches from a few invited dignitaries. In addition, Mngadi, along with other members of the office, maintains that this is an opportunity for staff and students to engage with one another. The march is particularly important because it will teach staff and students “to be aware of the diversity that exists within our institution, a diversity that transcends language, religion, and ethnicity – to name just a few. People will also learn to respect this diversity, and most importantly, to understand that all lives matter”, said Mngadi.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept